1. Home
  2. KRRO vs CAAS Comparison

KRRO vs CAAS Comparison

Compare KRRO & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • CAAS
  • Stock Information
  • Founded
  • KRRO 2014
  • CAAS N/A
  • Country
  • KRRO United States
  • CAAS China
  • Employees
  • KRRO N/A
  • CAAS N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • CAAS Auto Parts:O.E.M.
  • Sector
  • KRRO Health Care
  • CAAS Consumer Discretionary
  • Exchange
  • KRRO Nasdaq
  • CAAS Nasdaq
  • Market Cap
  • KRRO 125.4M
  • CAAS 130.9M
  • IPO Year
  • KRRO 2019
  • CAAS N/A
  • Fundamental
  • Price
  • KRRO $12.90
  • CAAS $4.19
  • Analyst Decision
  • KRRO Strong Buy
  • CAAS
  • Analyst Count
  • KRRO 7
  • CAAS 0
  • Target Price
  • KRRO $85.67
  • CAAS N/A
  • AVG Volume (30 Days)
  • KRRO 99.7K
  • CAAS 39.0K
  • Earning Date
  • KRRO 08-12-2025
  • CAAS 08-12-2025
  • Dividend Yield
  • KRRO N/A
  • CAAS 18.96%
  • EPS Growth
  • KRRO N/A
  • CAAS N/A
  • EPS
  • KRRO N/A
  • CAAS 0.96
  • Revenue
  • KRRO $4,821,000.00
  • CAAS $678,635,000.00
  • Revenue This Year
  • KRRO $65.08
  • CAAS N/A
  • Revenue Next Year
  • KRRO N/A
  • CAAS N/A
  • P/E Ratio
  • KRRO N/A
  • CAAS $4.43
  • Revenue Growth
  • KRRO N/A
  • CAAS 18.33
  • 52 Week Low
  • KRRO $10.29
  • CAAS $3.34
  • 52 Week High
  • KRRO $98.00
  • CAAS $5.37
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 51.40
  • CAAS 51.23
  • Support Level
  • KRRO $12.27
  • CAAS $4.10
  • Resistance Level
  • KRRO $15.15
  • CAAS $4.41
  • Average True Range (ATR)
  • KRRO 1.13
  • CAAS 0.15
  • MACD
  • KRRO 0.25
  • CAAS -0.00
  • Stochastic Oscillator
  • KRRO 57.01
  • CAAS 37.14

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: